237 related articles for article (PubMed ID: 28895757)
21. Pharmacology of novel synthetic stimulants structurally related to the "bath salts" constituent 3,4-methylenedioxypyrovalerone (MDPV).
Marusich JA; Antonazzo KR; Wiley JL; Blough BE; Partilla JS; Baumann MH
Neuropharmacology; 2014 Dec; 87():206-13. PubMed ID: 24594476
[TBL] [Abstract][Full Text] [Related]
22. Detection of new psychoactive substance use among emergency room patients: results from the Swedish STRIDA project.
Helander A; Bäckberg M; Hultén P; Al-Saffar Y; Beck O
Forensic Sci Int; 2014 Oct; 243():23-9. PubMed ID: 24726531
[TBL] [Abstract][Full Text] [Related]
23. Acute Methylenedioxypyrovalerone Toxicity.
Froberg BA; Levine M; Beuhler MC; Judge BS; Moore PW; Engebretsen KM; Mckeown NJ; Rosenbaum CD; Young AC; Rusyniak DE;
J Med Toxicol; 2015 Jun; 11(2):185-94. PubMed ID: 25468313
[TBL] [Abstract][Full Text] [Related]
24. Multi-organ dysfunction due to bath salts: are we aware of this entity?
Valsalan R; Varghese B; Soman D; Buckmaster J; Yew S; Cooper D
Intern Med J; 2017 Jan; 47(1):109-111. PubMed ID: 28076917
[TBL] [Abstract][Full Text] [Related]
25. MT-45, a new psychoactive substance associated with hearing loss and unconsciousness.
Helander A; Bäckberg M; Beck O
Clin Toxicol (Phila); 2014; 52(8):901-4. PubMed ID: 25175898
[TBL] [Abstract][Full Text] [Related]
26. [Increased abuse of the Internet drug MDPV in Västmanland. Severe cases of poisoning have given health care major problems].
Lindeman E; Hultén P; Ström S; Enlund M; Al-Saffar Y; Helander A
Lakartidningen; 2012 Oct 24-Nov 6; 109(43-44):1954-7. PubMed ID: 23198339
[No Abstract] [Full Text] [Related]
27. Active vaccination attenuates the psychostimulant effects of α-PVP and MDPV in rats.
Nguyen JD; Bremer PT; Ducime A; Creehan KM; Kisby BR; Taffe MA; Janda KD
Neuropharmacology; 2017 Apr; 116():1-8. PubMed ID: 27956054
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis and biological evaluation of a bi-specific vaccine against α-pyrrolidinovalerophenone (α-PVP) and 3,4-methylenedioxypyrovalerone (MDPV) in rats.
McClenahan SJ; Kormos CM; Gunnell M; Hambuchen MD; Lamb P; Carroll FI; Lewin AH; Peterson EC; Owens SM
Vaccine; 2020 Jan; 38(2):336-344. PubMed ID: 31629568
[TBL] [Abstract][Full Text] [Related]
29. Toxicological investigation of forensic cases related to the designer drug 3,4-methylenedioxypyrovalerone (MDPV): Detection, quantification and studies on human metabolism by GC-MS.
Grapp M; Kaufmann C; Ebbecke M
Forensic Sci Int; 2017 Apr; 273():1-9. PubMed ID: 28187296
[TBL] [Abstract][Full Text] [Related]
30. Toxicological Investigation of a Case Series Involving the Synthetic Cathinone α-Pyrrolidinohexiophenone (α-PHP) and Identification of Phase I and II Metabolites in Human Urine.
Grapp M; Kaufmann C; Schwelm HM; Neukamm MA
J Anal Toxicol; 2023 Mar; 47(2):162-174. PubMed ID: 35921233
[TBL] [Abstract][Full Text] [Related]
31. Neurobiology of 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinovalerophenone (α-PVP).
Glennon RA; Young R
Brain Res Bull; 2016 Sep; 126(Pt 1):111-126. PubMed ID: 27142261
[TBL] [Abstract][Full Text] [Related]
32. Pyrrolidinyl Synthetic Cathinones α-PHP and 4F-α-PVP Metabolite Profiling Using Human Hepatocyte Incubations.
Carlier J; Diao X; Giorgetti R; Busardò FP; Huestis MA
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33379373
[TBL] [Abstract][Full Text] [Related]
33. Postmortem tissue distribution of MDPV following lethal intoxication by "bath salts".
Wyman JF; Lavins ES; Engelhart D; Armstrong EJ; Snell KD; Boggs PD; Taylor SM; Norris RN; Miller FP
J Anal Toxicol; 2013 Apr; 37(3):182-5. PubMed ID: 23408250
[TBL] [Abstract][Full Text] [Related]
34. Tentative identification of the phase I and II metabolites of two synthetic cathinones, MDPHP and α-PBP, in human urine.
Kavanagh P; Gofenberg M; Shevyrin V; Dvorskaya O; Dowling G; Grigoryev A
Drug Test Anal; 2020 Oct; 12(10):1442-1451. PubMed ID: 32621389
[TBL] [Abstract][Full Text] [Related]
35. MDPV in forensic routine cases: Psychotic and aggressive behavior in relation to plasma concentrations.
Diestelmann M; Zangl A; Herrle I; Koch E; Graw M; Paul LD
Forensic Sci Int; 2018 Feb; 283():72-84. PubMed ID: 29275216
[TBL] [Abstract][Full Text] [Related]
36. Clinical manifestations and analytical reports for MDPHP acute intoxication cases.
Arillotta D; Totti A; Dimitrova A; Croce EB; Di Milia MG; Gambassi F; Gualco B; Pieraccini G; Mannaioni G; Vaiano F
J Pharm Biomed Anal; 2024 Apr; 241():115974. PubMed ID: 38277706
[TBL] [Abstract][Full Text] [Related]
37. The synthetic cathinone α-pyrrolidinovalerophenone (α-PVP): pharmacokinetic and pharmacodynamic clinical and forensic aspects.
Nóbrega L; Dinis-Oliveira RJ
Drug Metab Rev; 2018 May; 50(2):125-139. PubMed ID: 29540067
[TBL] [Abstract][Full Text] [Related]
38. Death following recreational use of designer drug "bath salts" containing 3,4-Methylenedioxypyrovalerone (MDPV).
Murray BL; Murphy CM; Beuhler MC
J Med Toxicol; 2012 Mar; 8(1):69-75. PubMed ID: 22271565
[TBL] [Abstract][Full Text] [Related]
39. Flakka: New Dangerous Synthetic Cathinone on the Drug Scene.
Patocka J; Zhao B; Wu W; Klimova B; Valis M; Nepovimova E; Kuca K
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33142953
[TBL] [Abstract][Full Text] [Related]
40. A case of fatal idiosyncratic reaction to the designer drug 3,4-methylenedioxypyrovalerone (MDPV) and review of the literature.
Desharnais B; Dazé Y; Huppertz LM; Mireault P; Skinner CD
Forensic Sci Med Pathol; 2017 Sep; 13(3):350-354. PubMed ID: 28668987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
